Vantage logo

The Wegovy wait continues

Novo Nordisk delays the full US launch of its obesity drug again, as Lilly breathes down its neck.

Vantage logo

The patent winter is coming

Biopharma is approaching the most painful period of patent loss for at least 30 years. Is M&A an answer?